Recent Finacing
Recent Raise
Arsenal Biosciences develops autologous T cell therapies for solid tumors using CRISPR-mediated insertion of large synthetic DNA cassettes, logic-gated therapeutic circuits, computational discovery, and nonviral clinical manufacturing.
